Lexicon Pharmaceuticals Inc (LXRX) — Financial Flexibility Index
Lexicon Pharmaceuticals Inc (LXRX) has a Financial Flexibility Index of -0.22x as of March 2026. Free cash flow of $-14.73 Million (operating CF $-14.73 Million minus capex $0.00) represents 0% of total liabilities ($65.96 Million). Check cash flow reinvestment rate of Lexicon Pharmaceuticals Inc to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Lexicon Pharmaceuticals Inc Financial Flexibility Index (1999–2025)
Historical Financial Flexibility Index trend for Lexicon Pharmaceuticals Inc across 27 annual periods. For the full cash flow conversion analysis, see how efficiently does Lexicon Pharmaceuticals Inc generate cash.
Annual Financial Flexibility Index for Lexicon Pharmaceuticals Inc (1999–2025)
Year-by-year free cash flow to debt coverage for Lexicon Pharmaceuticals Inc. Explore Lexicon Pharmaceuticals Inc (LXRX) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.88x | $-67.85 Million | $-67.85 Million | $77.45 Million | ▲ +24.9% |
| 2024 | -1.17x | $-177.75 Million | $-178.78 Million | $152.47 Million | ▲ +1.6% |
| 2023 | -1.18x | $-161.43 Million | $-161.90 Million | $136.32 Million | ▼ -4.4% |
| 2022 | -1.13x | $-87.53 Million | $-88.85 Million | $77.17 Million | ▲ +69.2% |
| 2021 | -3.68x | $-85.80 Million | $-87.02 Million | $23.31 Million | ▼ -22.1% |
| 2020 | -3.01x | $-142.88 Million | $-142.97 Million | $47.42 Million | ▼ -895.5% |
| 2019 | 0.38x | $113.88 Million | $113.81 Million | $300.61 Million | ▲ +179.2% |
| 2018 | -0.48x | $-148.51 Million | $-148.61 Million | $310.54 Million | ▲ +0.7% |
| 2017 | -0.48x | $-185.17 Million | $-185.39 Million | $384.44 Million | ▲ +12.6% |
| 2016 | -0.55x | $-175.40 Million | $-175.63 Million | $318.22 Million | ▼ -209.5% |
| 2015 | 0.50x | $185.69 Million | $184.78 Million | $368.98 Million | ▲ +224.8% |
| 2014 | -0.40x | $-75.54 Million | $-75.62 Million | $187.36 Million | ▲ +53.1% |
| 2013 | -0.86x | $-89.36 Million | $-91.08 Million | $104.00 Million | ▲ +3.9% |
| 2012 | -0.89x | $-93.97 Million | $-94.46 Million | $105.10 Million | ▼ -37.0% |
| 2011 | -0.65x | $-86.73 Million | $-87.94 Million | $132.94 Million | ▲ +3.7% |
| 2010 | -0.68x | $-81.24 Million | $-82.37 Million | $119.86 Million | ▲ +27.9% |
| 2009 | -0.94x | $-88.65 Million | $-89.02 Million | $94.26 Million | ▲ +33.9% |
| 2008 | -1.42x | $-93.41 Million | $-95.60 Million | $65.68 Million | ▼ -62.5% |
| 2007 | -0.88x | $-72.42 Million | $-74.32 Million | $82.72 Million | ▼ -72.0% |
| 2006 | -0.51x | $-53.33 Million | $-56.91 Million | $104.77 Million | ▼ -294.9% |
| 2005 | 0.26x | $34.72 Million | $23.44 Million | $132.91 Million | ▲ +177.6% |
| 2004 | -0.34x | $-30.45 Million | $-42.26 Million | $90.39 Million | ▼ -1274.2% |
| 2003 | -0.02x | $-2.89 Million | $-7.72 Million | $117.98 Million | ▲ +91.3% |
| 2002 | -0.28x | $-9.03 Million | $-28.79 Million | $31.87 Million | ▼ -35.5% |
| 2001 | -0.21x | $-4.52 Million | $-17.99 Million | $21.62 Million | ▼ -144.0% |
| 2000 | 0.48x | $6.21 Million | $-1.50 Million | $13.06 Million | ▲ +221.8% |
| 1999 | -0.39x | $-5.50 Million | $-9.60 Million | $14.10 Million | — |